These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 34931176)

  • 1. Iota-carrageenan extracted from red algae is a potent inhibitor of SARS-CoV-2 infection in reconstituted human airway epithelia.
    Bovard D; van der Toorn M; Schlage WK; Constant S; Renggli K; Peitsch MC; Hoeng J
    Biochem Biophys Rep; 2022 Mar; 29():101187. PubMed ID: 34931176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iota-carrageenan neutralizes SARS-CoV-2 and inhibits viral replication in vitro.
    Morokutti-Kurz M; Fröba M; Graf P; Große M; Grassauer A; Auth J; Schubert U; Prieschl-Grassauer E
    PLoS One; 2021; 16(2):e0237480. PubMed ID: 33596218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ColdZyme Maintains Integrity in SARS-CoV-2-Infected Airway Epithelia.
    Posch W; Vosper J; Zaderer V; Noureen A; Constant S; Bellmann-Weiler R; Lass-Flörl C; Wilflingseder D
    mBio; 2021 Apr; 12(2):. PubMed ID: 33906927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-Free Nasal Spray as a Barrier against SARS-CoV-2 and Its Delta Variant: In Vitro Study of Safety and Efficacy in Human Nasal Airway Epithelia.
    Fais F; Juskeviciene R; Francardo V; Mateos S; Guyard M; Viollet C; Constant S; Borelli M; Hohenfeld IP
    Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Saliva of Probands Sucking an Iota-Carrageenan Containing Lozenge Inhibits Viral Binding and Replication of the Most Predominant Common Cold Viruses and SARS-CoV-2.
    Morokutti-Kurz M; Unger-Manhart N; Graf P; Rauch P; Kodnar J; Große M; Setz C; Savli M; Ehrenreich F; Grassauer A; Prieschl-Grassauer E; Schubert U
    Int J Gen Med; 2021; 14():5241-5249. PubMed ID: 34526804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iota-carrageenan and xylitol inhibit SARS-CoV-2 in Vero cell culture.
    Bansal S; Jonsson CB; Taylor SL; Figueroa JM; Dugour AV; Palacios C; Vega JC
    PLoS One; 2021; 16(11):e0259943. PubMed ID: 34797868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The antiviral activity of iota-, kappa-, and lambda-carrageenan against COVID-19: A critical review.
    Frediansyah A
    Clin Epidemiol Glob Health; 2021; 12():100826. PubMed ID: 34222718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human Surfactant Protein D Binds Spike Protein and Acts as an Entry Inhibitor of SARS-CoV-2 Pseudotyped Viral Particles.
    Hsieh MH; Beirag N; Murugaiah V; Chou YC; Kuo WS; Kao HF; Madan T; Kishore U; Wang JY
    Front Immunol; 2021; 12():641360. PubMed ID: 34054808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Air-Liquid-Interface Differentiated Human Nose Epithelium: A Robust Primary Tissue Culture Model of SARS-CoV-2 Infection.
    Tran BM; Grimley SL; McAuley JL; Hachani A; Earnest L; Wong SL; Caly L; Druce J; Purcell DFJ; Jackson DC; Catton M; Nowell CJ; Leonie L; Deliyannis G; Waters SA; Torresi J; Vincan E
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Astodrimer sodium nasal spray forms a barrier to SARS-CoV-2 in vitro and preserves normal mucociliary function in human nasal epithelium.
    Paull JRA; Luscombe CA; Seta A; Heery GP; Bobardt MD; Gallay PA; Constant S; Castellarnau A
    Sci Rep; 2024 Sep; 14(1):21259. PubMed ID: 39261670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protease Inhibitors: Candidate Drugs to Inhibit Severe Acute Respiratory Syndrome Coronavirus 2 Replication.
    Yamaya M; Nishimura H; Deng X; Kikuchi A; Nagatomi R
    Tohoku J Exp Med; 2020 May; 251(1):27-30. PubMed ID: 32448818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Replication of Severe Acute Respiratory Syndrome Coronavirus 2 in Human Respiratory Epithelium.
    Milewska A; Kula-Pacurar A; Wadas J; Suder A; Szczepanski A; Dabrowska A; Owczarek K; Marcello A; Ochman M; Stacel T; Rajfur Z; Sanak M; Labaj P; Branicki W; Pyrc K
    J Virol; 2020 Jul; 94(15):. PubMed ID: 32434888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long Period Modeling SARS-CoV-2 Infection of in Vitro Cultured Polarized Human Airway Epithelium.
    Hao S; Ning K; Kuz CA; Vorhies K; Yan Z; Qiu J
    bioRxiv; 2020 Aug; ():. PubMed ID: 32869024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimized Pseudotyping Conditions for the SARS-COV-2 Spike Glycoprotein.
    Johnson MC; Lyddon TD; Suarez R; Salcedo B; LePique M; Graham M; Ricana C; Robinson C; Ritter DG
    J Virol; 2020 Oct; 94(21):. PubMed ID: 32788194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr Virus Lytic Replication Induces ACE2 Expression and Enhances SARS-CoV-2 Pseudotyped Virus Entry in Epithelial Cells.
    Verma D; Church TM; Swaminathan S
    J Virol; 2021 Jun; 95(13):e0019221. PubMed ID: 33853968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Geraniin Inhibits the Entry of SARS-CoV-2 by Blocking the Interaction between Spike Protein RBD and Human ACE2 Receptor.
    Kim YS; Chung HS; Noh SG; Lee B; Chung HY; Choi JG
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transport of Designed Ankyrin Repeat Proteins through reconstituted human bronchial epithelia and protection against SARS-CoV-2.
    Künzi L; Ryter S; Cornelius A; Leni Z; Baumlin N; Salathe M; Walser M; Engler O; Geiser M
    Sci Rep; 2023 Apr; 13(1):5537. PubMed ID: 37016030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Air exposure and cell differentiation are essential for investigation of SARS-CoV-2 entry genes in human primary airway epithelial cells
    Kasper B; Yue X; Goldmann T; Gülsen A; Kugler C; Yu X; Petersen F
    Front Med (Lausanne); 2022; 9():897695. PubMed ID: 36148455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice.
    Bao L; Deng W; Huang B; Gao H; Liu J; Ren L; Wei Q; Yu P; Xu Y; Qi F; Qu Y; Li F; Lv Q; Wang W; Xue J; Gong S; Liu M; Wang G; Wang S; Song Z; Zhao L; Liu P; Zhao L; Ye F; Wang H; Zhou W; Zhu N; Zhen W; Yu H; Zhang X; Guo L; Chen L; Wang C; Wang Y; Wang X; Xiao Y; Sun Q; Liu H; Zhu F; Ma C; Yan L; Yang M; Han J; Xu W; Tan W; Peng X; Jin Q; Wu G; Qin C
    Nature; 2020 Jul; 583(7818):830-833. PubMed ID: 32380511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel antiviral formulation containing caprylic acid inhibits SARS-CoV-2 infection of a human bronchial epithelial cell model.
    Purves K; Haverty R; O'Neill T; Folan D; O'Reilly S; Baird AW; Scholz D; Mallon PW; Gautier V; Folan M; Fletcher NF
    J Gen Virol; 2023 Feb; 104(2):. PubMed ID: 36787173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.